In this episode of Careers in Discovery, we're joined by Lindsay Davies, Chief Scientific Officer at NextCell Pharma. Lindsay’s work focuses on harnessing the potential of umbilical cord-derived cells to treat autoimmune diseases, especially type 1 diabetes. She shares her inspiring journey from academia to leading cutting-edge cell therapy trials, driven by a commitment to patient-centred science and innovation.

Lindsay also highlights her role in mentoring the next generation of scientists and her team’s exciting plans for QVance, a new venture to support advanced therapies with robust quality analytics.

If you’re curious about the future of cell therapy, the real-world impact of innovative science, and a career built on passion and purpose, this is an episode you won’t want to miss.